Herborium Group, Inc. Share Price Other OTC
Equities
HBRM
US42703A2087
Biotechnology & Medical Research
Sales 2010 | 262K 21.81M | Sales 2011 | 234K 19.52M | Capitalization | 210K 17.52M |
---|---|---|---|---|---|
Net income 2010 | - 0 | Net income 2011 | - 0 | EV / Sales 2010 | 10.7 x |
Net Debt 2010 | 588K 48.92M | Net Debt 2011 | 621K 51.72M | EV / Sales 2011 | 3.55 x |
P/E ratio 2010 |
-4.35
x | P/E ratio 2011 |
-0.97
x | Employees | - |
Yield 2010 * |
-
| Yield 2011 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Agnes Olszewski
CEO | Chief Executive Officer | 67 | 04/02/04 |
John Donahue
AUD | Comptroller/Controller/Auditor | 74 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Agnes Olszewski
CEO | Chief Executive Officer | 67 | 04/02/04 |
1st Jan change | Capi. | |
---|---|---|
+9.10% | 114B | |
+11.46% | 104B | |
-12.66% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-2.93% | 17.89B | |
+8.27% | 14.28B | |
+34.99% | 12.55B |